parenteral preparation pdf
Introduction to Parenteral Preparations
Define a parenteral preparation List various routes of parenteral administration Describe advantages and disadvantages of the parenteral route of administration Discuss the role of safety accuracy and attitude in risk prevention associated with parenteral preparation |
A Detailed Concepts on Parenteral Preparation
ABSTRACT Parenteral preparations are defined as solutions suspensions emulsions for injection or infusion powders for injection or infusion gels for injection and implants They are sterile preparations intended to be administrated directly into the systemic circulation in human or animal body |
Chapter 13 Formulation Development of Parenteral Products
This chapter provides an overview of the development of injectable (parenteral) drug products Injectable drug products are relatively specialized and diverse depending on both the location and type of disease to be treated in a patient Developing an optimized formulation around a certain type of product will determine not only whether or not the |
Parenteral preparations
Parenteral preparations are sterile preparations containing one or more active ingredients intended for administration by injection infusion or implantation into the body They are packaged in either single-dose or multidose containers |
PARENTERAL PREPARATIONS
PARENTERAL PREPARATIONS INTRODUCTION Parenteral (Gk para enteron beside the intestine) dosage forms differ from all other drug dosage forms because they are injected directly into body tissue through the primary protective systems of the human body the skin and mucous membranes |
What are the different routes of parenteral administration?
While many routes of parenteral administration are available, all of which bypass the intestinal tract, the intravenous, intramuscular, and subcutaneous routes of administration are the most commonly used. Table 1-1 lists various routes and locations of delivery of parenteral admin-istration.
Why is a standardized method important for parenteral medication administration?
It is important to follow a standardized method for parenteral medication administration. Agency policies on medication preparation, administration, and documentation may vary, so it is important to receive agency training on using their medication system to avoid errors.
What is a parenteral medication?
18.1. ADMINISTRATION OF PARENTERAL MEDICATIONS INTRODUCTION Administering medication by the parenteral route is defined as medications placed into the tissues and the circulatory system by injection. There are several reasons why medications may be prescribed via the parenteral route.
How to prepare a parenteral solution?
Preparation of Solution:- The various ingredients of the formulation of parental preparations are weighed and collected in the preparation room. the raw materials required in the preparation of parenteral products should be pure. water for injection free from pyrogens and microorganisms are used in preparation of parenteral products.
Objectives
This chapter provides an overview of the development of injectable (parenteral) drug products. Injectable drug products are relatively specialized and diverse, depending on both the location and type of disease to be treated in a patient. Developing an optimized formulation around a certain type of product will determine not only whether or not the
Terms
Buffer Capacity: the strength of a buffer system; the amount of acid or base that can be added before the solution pH shifts Buffer System: a weak acid and its conjugate salt that prevents the pH from shifting in a solution Emulsion: in colloid chemistry, a suspension of one liquid (oil) in another (aqueous) Endotoxin (Pyrogen): a lipopolysaccharid
Basic theory
Parenteral (para enteron—beside the intestine) administration is the introduction into the body of nutrition, medications, or other substances other than by the alimentary canal. Unlike taking medications orally or rectally, introducing a drug into the body by parenteral administration poses far greater risk since the body’s natural defenses are by
Injectable Suspensions
Suspensions are products where the active ingredient is extremely insoluble in the solution used to deliver it (the vehicle). Suspensions are formulated as such so when they are injected to a precise location, the drug crystals slowly dissolve, resulting in a controlled, slow release of the drug to the surrounding capillaries where it is absorbed i
Structured vehicle
The structured vehicle approach is based on the viscosity of the suspending solution (vehicle) and how the viscosity changes with shear force (shaking). The study of viscosity (Rheology) is an involved science, and liquids behave differently depending on their characteristics. Many fluids follow what is known as Newtonian Flow, which states that
Routes of Administration
A parenteral product may be administered via several different routes based on different criteria, including onset of action, bioavailability, and delayed release. The most common routes of administration are: subcutaneous – under the skin intramuscular – into a muscle intravenous – into a vein either by bolus (directly into a vein) or infusion (di
Specifications
Injectable drug products, like other drug products, must meet certain specifications in order to be released for sale to the public. Unlike oral drugs (tablets, capsules, etc.), injectable drug products have additional specifications that must be met due to these products bypassing the body’s natural defenses against microorganisms. Mandatory attri
Introduction
Formulation of a stable, safe, and effective injectable drug product is a sizable, challenging task involving many scientific disciplines and encompassing years of research and development. Once a drug is discovered and the first patent is filed, the company holding the patent has 17 years of market exclusivity for the drug before generic drug comp
Pre-formulation assessment
The pre-formulation assessment is an information gathering process to ensure that all of the required information is in place to begin the pre-formulation development studies. Having all of this information in place before starting pre-formulation development studies saves the development scientist both time and effort. Much of the information need
Pre-formulation development
The pre-formulation studies are designed essentially to find the conditions in which the molecule is most stable. Once these conditions are understood, the goal of the formulation development studies is to achieve these conditions through either the addition of excipients or how the product is processed (i.e., lyophilization). Pre-formulation devel
Solubility
The solubility of the drug can be a challenge for the development scientist. In some cases a bulk drug simply floats on top of the water used to dissolve it. In this case, solubility studies must be conducted. There are several ways to enhance the solubility of poorly soluble compounds; when doing so, the following questions should be addressed: Ca
Formulation development
The goal of the formulation development work is to establish the optimal conditions determined in the pre-formulation development studies. These conditions are achieved through procedures such as the addition of excipients, the control of oxygen, and the control of hydrolysis (through lyophilization). Additional information regarding the drug produ
Antioxidants, stabilizers, surfactants, and bulking agents
Occasionally additional steps must be taken to help stabilize unstable products. If the pre-formulation studies were performed correctly, the information regarding the damaging effects of factors such as light, temperature, water, and oxygen should all be known prior to starting the formulation development studies. If a drug is shown to be suscepti
Accelerated Stability Studies
During both the pre-formulation and formulation development studies, accelerated stability studies are conducted to determine the effects that different factors, such as excipients and processing, have on both the short- and long-term stability of the drug product. Typically formulations are prepared with variations, including pH, stabilizer, buffe
Process compatibility and scale-up
Once the final formulation has been developed, transferring the formulation, and requirements for filling and freeze-drying, to a manufacturing facility must be performed to ensure that the product can be made flawlessly while meeting the same release specifications that were established during the development studies. biomanufacturing.org
Scale-Up
Once the formulation is developed; the process compatibility studies are complete; and the batch record has been written and approved, the product is ready to be scaled up from a lab batch to a large batch prepared in production. This can be either a fairly simple process for small-molecule, water-based formulations or a relatively complex process
Check Your Knowledge
Which of the following is not a disadvantage of using an injectable drug product? pain on injection bypasses the body’s natural defenses against infection drug may be unable to pass through a needle site needs to be sterilized before administration Which of the following is not a type of injectable product? solutions ready for transfer dry, solub
![Formulation of Parenteral Preparation Adjuvants L-3 Unit-4 Industrial Pharmacy 5th Sem Formulation of Parenteral Preparation Adjuvants L-3 Unit-4 Industrial Pharmacy 5th Sem](https://pdfprof.com/FR-Documents-PDF/Bigimages/OVP.V4AYYebsxxQpz12AbZ8WmwEsDh/image.png)
Formulation of Parenteral Preparation Adjuvants L-3 Unit-4 Industrial Pharmacy 5th Sem
![Processing \ Procedure of Preparation of Parenteral Preparation L-4 Unit-4 Industrial Pharmacy Processing \ Procedure of Preparation of Parenteral Preparation L-4 Unit-4 Industrial Pharmacy](https://pdfprof.com/FR-Documents-PDF/Bigimages/OVP.sJjaNBuxy6Nr6SPbwv5qrAEsDh/image.png)
Processing \ Procedure of Preparation of Parenteral Preparation L-4 Unit-4 Industrial Pharmacy
![Production facilities of Parenteral Preparation Aseptic Area L-5 Unit-4 Industrial Pharmacy Production facilities of Parenteral Preparation Aseptic Area L-5 Unit-4 Industrial Pharmacy](https://pdfprof.com/FR-Documents-PDF/Bigimages/OVP.od4zpfUq1dnhjO8ZruWXzgEsDh/image.png)
Production facilities of Parenteral Preparation Aseptic Area L-5 Unit-4 Industrial Pharmacy
Abbreviations: -
Aug 22 2020 Formulation of injections |
Annex 6 WHO good manufacturing practices for sterile
Preparation of solutions when unusually at risk. 13.8 Filled containers of parenteral products should be inspected individually for extraneous contamination ... |
Iron (parenteral preparations except for iron dextran): CMDh
Taking into account the PRAC Assessment Report on the PSUR(s) for iron (parenteral preparations except for iron dextran) the scientific conclusions are as |
PARENTERAL PREPARATIONS
Due to the advent of biotechnology parenteral products have grown in number and usage around the world. Page 4. Characteristics of parenteral dosage forms. • |
Q 6 A Specifications: Test Procedures and Acceptance Criteria for
3.3.2.3 Parenteral Drug Products: The following tests may be applicable to parenteral drug products. a) Uniformity of dosage units: This term includes both |
Guideline on the quality of water for pharmaceutical use
Jul 20 2020 ... Parenteral preparations (0520) and Preparations ... Water for Injections (WFI) is water for the preparation of medicines for parenteral ... |
<788> PARTICULATE MATTER IN INJECTIONS
Not all parenteral preparations can be examined for sub-visible particles by one or both of these methods. When Method 1 is not applicable e.g. in case of |
BRIEFING 〈1〉 Injections USP 28 page 2201. The United States
Nov 21 2016 The Parenteral Products—Industrial Expert Committee in conjunction with the Pharmaceutical. Discussion Group (PDG) have agreed to harmonize the ... |
Annex 9 Guidelines on packaging for pharmaceutical products
Parenteral preparations. These are usually supplied in glass ampoules the container into the preparation. Closures for these containers should be of a ... |
Guideline on the Investigation of Bioequivalence
Jan 20 2010 However |
PARENTERAL PREPARATIONS
Characteristics of parenteral dosage forms. • Parenteral products are unique from any other type of pharmaceutical dosage form for the following reasons:. |
Abbreviations: -
Quality control tests of parenteral products. Ophthalmic Preparations: Introduction formulation considerations; formulation of eye drops |
Sterile/Parenteral Dosage Forms
Types of Parenteral Preparations. Small Volume Parenterals: An injection that is packed in containers labelled as containing 100 mL or less. |
ICH Topic Q 6 A Specifications: Test Procedures and Acceptance
NEW DRUG SUBSTANCES AND NEW DRUG PRODUCTS: CHEMICAL c) Sterility: All parenteral products should have a test procedure and acceptance criterion for. |
Iron (parenteral preparations except for iron dextran): CMDh
06-Sept-2020 product information of products containing ferric carboxymaltose should ... (parenteral preparations except for iron dextran) is unchanged ... |
Guideline on the quality of water for pharmaceutical use
13-Nov-2018 Committee for Medicinal Products for Human Use (CHMP) ... preparations for parenteral administration (sterilised water for injections). |
1 INJECTIONS INTRODUCTION Parenteral articles are preparations
21-Nov-2016 An Injection is a preparation intended for parenteral administration and/or for constituting or diluting a parenteral article prior to. |
<788> PARTICULATE MATTER IN INJECTIONS
Not all parenteral preparations can be examined for sub-visible particles by one or both of these methods. When Method 1 is not applicable e.g. in case of |
REVIEWS Antimicrobial Preservative Use in Parenteral Products
preservatives that are commonly used in licensed parenteral products to date. The Keywords: parenteral; formulation; antimicrobial preservatives; ... |
Comparison of serum levels following the administration of oral and
ADMINISTRATION OF ORAL AND PARENTERAL. PREPARATIONS OF PENICILLIN TO INFANTS. AND CHILDREN OF VARIOUS AGE GROUPS. NANCY N. HUANG M.D. |
Parenteral preparations
Parenteral preparations are sterile preparations containing one or more active ingredients intended for administration by injection, infusion or implantation into |
Introduction to Parenteral Preparations
parenteral administration from manufactured sterile products to the preparation and administration of parenteral preparations /discguide797-2008 pdf |
PARENTERAL PREPARATIONS
Characteristics of parenteral dosage forms • Parenteral products are unique from any other type of pharmaceutical dosage form for the following reasons: |
Parenteral formulations
Formulation of Parenteral Solutions 10 Inert gases 1 Active drug 2 Solvent, co -solvent 3 Surfactants 5 Preservatives 9 Chelating agents 8 Antioxidant 7 |
Parenteral Preparations
Because of the advent of biotechnology, parenteral products have grown in number and be developed †www eudra org/emea/ pdf s/CPMP_QWP_159_96 pdf |
Sterile/Parenteral Dosage Forms - MESs College of Pharmacy, Sonai
Types of Parenteral Preparations Small Volume Parenterals: An injection that is packed in containers labelled as containing 100 mL or less Examples: Solution |
A Comprehensive Review in Parenteral Formulations - Acta Scientific
30 jui 2020 · pects regarding parenteral products advantages, disadvantages, routes of administration, additives, preparation, types of containers and quality |
Formulation Development of Parenteral Products - Biomanufacturing
This chapter provides an overview of the development of injectable (parenteral) drug products Injectable drug products are relatively specialized and diverse, |
UNIT 3 PARENTERAL AND EXTERNAL PREPARATIONS
Evaluation of Parenteral Products Large Volume Parenterals Irrigation Solutions Dialysis Solutions 3 4 Ophthalmic Products Eye Drops Other Ophthalmic |
STERILITY TESTING OF PARENTERAL DRUGS - Sartorius
sterile formulations, i e parenterals intended for Sterility testing of parenterals is a decisive criterion contributing to drug safety Without this test, no sterile medical preparation may be released package and save the data as a PDF file in ▷ |